FDA Approved: PROPYLTHIOURACIL — Supplemental Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

FDA approved a supplemental application for Propylthiouracil from Macleods Pharmaceuticals Limited (ANDA208867).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Disease
• Hyperthyroidism
• Thyrotoxic Crisis
• Toxic Multinodular Goiter

Drugs mentioned

• Propylthiouracil (propylthiouracil)

Snippet

SUPPL AP for PROPYLTHIOURACIL (PROPYLTHIOURACIL)